XEIA Venture Partners — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull.
Deep TechHealthtechMedical Devices
José Morales(Dr.)
Co-investorsDevice of Tomorrow CapitalSmartGateVC
Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in
Co-investorsArtesianASDF VenturesBlackbird VenturesDivergent CapitalEmpath VenturesIrregular Expressions+5 more
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)inNicolette Driscoll(Founder)in
Co-investorsDevice of Tomorrow CapitalDolby Family VenturesEmpath VenturesFuture VenturesGreyMatterMana Ventures+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












